{
    "startDate": "2020-01-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "PSTV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 9266000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 951000
            },
            {
                "label": "Inventories, net",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 107000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 469000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 10793000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 2014000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 707000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 18000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 372000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 13904000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 3608000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 139000
            },
            {
                "label": "Term loan obligations, net of discount",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 6026000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 9773000
            },
            {
                "label": "Noncurrent operating lease liability",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 589000
            },
            {
                "label": "Warrant liability",
                "concept": "WarrantsAndRightsOutstanding",
                "unit": "usd",
                "value": 242000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10604000
            },
            {
                "label": "Commitments and contingencies (Note 9)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,959 shares issued and outstanding at June 30, 2020 and December 31, 2019",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value; 100,000,000 shares authorized; 4,273,857 and 3,880,588 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 431492000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -428196000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 3300000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 13904000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -2926000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 188000
            },
            {
                "label": "Amortization of deferred financing costs and debt discount",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 275000
            },
            {
                "label": "In process research and development acquired from NanoTx Therapeutics",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 781000
            },
            {
                "label": "Non cash lease expense.",
                "concept": "pstv:NonCashLeaseExpense",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Change in fair value of warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -2423000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 55000
            },
            {
                "label": "Loss on sale of business",
                "concept": "GainLossOnSaleOfOtherAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -218000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other current assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": -487000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -54000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 371000
            },
            {
                "label": "Deferred revenues",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows used in operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -2911000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "In process research and development acquired from NanoTx Therapeutics",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 400000
            },
            {
                "label": "Proceeds from sale of business",
                "concept": "ProceedsFromDivestitureOfBusinesses",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows provided by (used in) investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -423000
            },
            {
                "label": "Principal payments of long-term obligations",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 5307000
            },
            {
                "label": "Payment of financing lease liability",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 51000
            },
            {
                "label": "Proceeds from warrant exercises.",
                "concept": "pstv:ProceedsFromWarrantExercises1",
                "unit": "usd",
                "value": 366000
            },
            {
                "label": "Proceeds from sale of common stock, net",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows used in financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -4992000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net decrease in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -8326000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 372000
            },
            {
                "label": "Common stock issued in payment for in process research and development.",
                "concept": "pstv:CommonStockIssuedInPaymentForInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 381000
            }
        ],
        "ic": [
            {
                "label": "Revenue earned during the period from non-product related activities and revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in government contract and other agreements.",
                "concept": "pstv:GovernmentContractsAndOther",
                "unit": "usd",
                "value": 303000
            },
            {
                "label": "Sales and marketing",
                "concept": "SellingAndMarketingExpense",
                "unit": "usd",
                "value": 215000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2832000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 5096000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -4793000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 45000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 601000
            },
            {
                "label": "Change in fair value of warrants",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -2423000
            },
            {
                "label": "Total other income (expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1867000
            },
            {
                "label": "Loss from continuing operations",
                "concept": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -2926000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -2926000
            },
            {
                "label": "Basic and diluted net loss per share attributable to common stockholders - continuing operations",
                "concept": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
                "unit": "usd/shares",
                "value": -0.74
            },
            {
                "label": "Net loss per share, basis and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.74
            },
            {
                "label": "Basic and diluted weighted average shares used in calculating net loss per share attributable to common stockholders",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 3967392
            }
        ]
    }
}